« All Events
Informa RNA Leaders USA Congress
September 4 @ 8:00 am - September 5 @ 5:00 pm
SCIENTIFIC, CLINICAL AND COMMERCIAL DEVELOPMENT OF RNA THERAPEUTICS AND VACCINES
Discover, develop & get to market by assessing new data & case studies from global RNA experts across Oligo-Based Therapeutics, mRNA Vaccines & Therapeutics and Next Gen RNA & Delivery Tools
REGISTER»
mRNA Vaccine & Therapeutics
- Delve in pre-clinical and clinical mRNA therapeutics and vaccine advancement for oncology cardiology, respiratory, neurology & rare diseases
- Progress mRNA 2.0 modalities such as self-amplifying RNAs and self-replicating RNAs.
Oligo-Based RNA Therapeutics
- Progress & assess the development of antisense oligonucleotides & siRNAs into the clinic for rare disease and chronic indications.
- Explore scientific approaches in the expansion of micro & non-coding RNAs.
Next-Gen RNA
- Uncover emerging RNA modalities and applications such as circular RNAs, dark genome, RNA editing, diagnostics, RNA editing and cell therapy.
- Understand novel RNA targets and approaches including small molecule drug discovery, deeper RNA biological MOAs.
Delivery & Process Development
- Discover novel delivery techniques beyond standard LNP and extrahepatic delivery, delivery solutions short RNAs including conjugates and naked formulations and optimising payloads.
- Assess platforms and raw materials to reduce mRNA production at scale and translate regulatory outlines to mRNA therapeutics.
Biotech Innovation Showcase
- Showcasing early-stage innovative technologies to tackle key challenges such as delivery, cell/tissue specificity and manufacturing cost reductions.
- Highlight scientific advancements for new disease targets to address unmet medical needs with RNA drug products.
CXO Forum
- Tailored for executives from private RNA Biotech companies to engage in discussions on specific commercial routes within the RNA field amongst peers.
- Gaining insights from investor and pharma leaders on case studies of business critical activities such as biotech valuations and how to partner with pharma.
